Related Experiment Video

Updated: Jun 30, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
03:40

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Published on: December 8, 2023

Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients

Kimberly Tamura1, Richard Drew

  • 1Campbell University School of Pharmacy, Buies Creek, North Carolina, USA.

Drugs of Today (Barcelona, Spain : 1998)
|September 23, 2008
PubMed

Insights

Invasive fungal infections (IFIs) are a serious risk for hematopoietic stem cell transplant (HSCT) patients. Antifungal prophylaxis is key, with newer agents showing promise for high-risk individuals.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Pharmacology

Background:

  • Invasive fungal infections (IFIs) are a significant complication in hematopoietic stem cell transplant (HSCT) recipients.
  • Candida and Aspergillus species are the most common pathogens causing IFIs.
  • Allogeneic transplant and acute graft-versus-host disease increase IFI risk.

Purpose of the Study:

  • To review current strategies for antifungal prophylaxis in HSCT recipients.
  • To identify optimal methods for risk stratification to guide prophylaxis decisions.
  • To discuss the role of various antifungal agents in preventing IFIs.

Main Methods:

  • Review of current literature and guidelines on antifungal prophylaxis in HSCT.
  • Analysis of risk factors associated with IFIs in HSCT patients.
  • Evaluation of the efficacy of different antifungal agents.

Main Results:

  • Fluconazole has been a standard for lower-risk patients.
  • Newer agents like posaconazole and micafungin demonstrate efficacy.
  • Risk stratification is crucial for targeted antifungal prophylaxis.

Conclusions:

  • Optimizing antifungal prophylaxis in HSCT recipients requires accurate risk assessment.
  • Posaconazole and micafungin represent valuable options for IFI prevention.
  • Continued research is needed to refine prophylaxis strategies and drug selection.

More Related Videos

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...